CSIMarket
 


Lazuriton Nano Biotechnology (u.s.a.) Inc.  (LNBI)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Lazuriton Nano Biotechnology (u.s.a.)'s Quick Ratio

LNBI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




LNBI Quick Ratio (Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
Y / Y Current Liabilities Change 51.72 % 61.45 % 88.71 % 104.92 % 125.7 %
Y / Y Cash & cash equivalent Change 12.72 % 0.34 % 0.34 % 0.25 % 0.25 %
Quick Ratio MRQ 0.01 0.01 0.01 0.01 0.01
Overall Ranking # # # # #
Seq. Current Liabilities Change 6.68 % 9.9 % 8.57 % 19.19 % 13.52 %
Seq. Cash & cash equivalent Change 12.53 % 0 % 0.17 % 0 % 0.17 %



Quick Ratio second quarter 2019 Comment
Due to increase in Current Liabilities in the second quarter 2019, Quick Ratio fell to 0.01 below Lazuriton Nano Biotechnology (u.s.a.) Inc. average.

Within Biotechnology & Drugs industry 216 other companies have achieved higher Quick Ratio than Lazuriton Nano Biotechnology (u.s.a.) in second quarter 2019. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are LNBI Segments?
See Quick Ratio LNBI on the trailing twelve month basis
Quick Ratio second quarter 2019 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 217
Healthcare Sector # 863
Overall Market # 4765


Quick Ratio Statistics
High Average Low
0.44 0.05 0.01
(Dec 31 2016)   (Mar 31 2019)




Financial Statements
Lazuriton Nano Biotechnology (u.s.a.)'s Current Liabilities $ 0 Millions Visit LNBI's Balance sheet
Lazuriton Nano Biotechnology (u.s.a.)'s Cash & cash equivalent $ 0 Millions Visit LNBI's Balance sheet
Source of LNBI's Sales Visit LNBI's Sales by Geography




Companies with similar Quick Ratio in the quarter endingJun 30 2019, within Biotechnology & Drugs Industry Quick RatioJun 30 2019 MRQ Cash & cash equivalentJun 30 2019 MRQ Current Liabilities
Gt Biopharma Inc   0.02 $ 0.264  Millions$ 16.731  Millions
Mount Tam Biotechnologies, Inc.  0.02 $ 0.042  Millions$ 2.661  Millions
Burzynski Research Institute Inc  0.01 $ 0.003  Millions$ 0.213  Millions
Mymetics Corp  0.01 $ 0.670  Millions$ 63.567  Millions
Nascent Biotech Inc   0.01 $ 0.005  Millions$ 0.626  Millions
Amyris Inc   0.01 $ 1.433  Millions$ 189.876  Millions
Predictive Oncology Inc   0.01 $ 0.070  Millions$ 9.456  Millions
Ridgefield Acquisition Corp  0.01 $ 0.002  Millions$ 0.249  Millions
Lazuriton Nano Biotechnology (u.s.a.) Inc.  0.01 $ 0.001  Millions$ 0.233  Millions
Regen Biopharma Inc  0.01 $ 0.071  Millions$ 12.368  Millions
Therapeutic Solutions International Inc 0.00 $ 0.007  Millions$ 1.851  Millions
Boston Therapeutics Inc 0.00 $ 0.011  Millions$ 5.462  Millions
Immune Therapeutics Inc 0.00 $ 0.022  Millions$ 12.553  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AIRT's Profile

Stock Price

AIRT's Financials

Business Description

Fundamentals

Charts & Quotes

AIRT's News

Suppliers

AIRT's Competitors

Customers & Markets

Economic Indicators

AIRT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071